The products information on this page is exclusively reserved for Healthcare Professionals

HES Coils

GEL THE NEC: Registry for Study of Coils in Intracranial Aneurysms

"Endovascular treatment of intracranial aneurysms with HydroSoft coils resulted in complete/near complete occlusion rates of 88% and a major complication rate of 1.8%."

Patients: 599
Countries: US, UK, China, Korea & Japan
Clinical Centers: 27
Design: Single arm prospective
Scope: Patients 21 – 90 y.o. with a ruptured or unruptured aneurysm, 3-15mm, H&H<4.
Purpose: Assess safety and efficacy of treating aneurysms with Hydrosoft coils used as finishing coils.

Endpoints

Recanalization or recurrence rates at 6 – 18 months post coiling (assessed by Corelab)

Efficacy results

Successful deployment of HydroSoft coils: 96.4%
Complete occlusion rate at 9 months: 63.2%
Adequate occlusion rate at 9 months: 88.4%
Recanalization: 10.8%
Retreatment: 3.4%

Safety results

Procedure-related mortality: 0.5%
Procedure-related major morbidity: 1.3%

Study publications

GEL THE NEC: a prospective registry evaluating the safety, ease of use, and efficacy of the HydroSoft coil as a finishing device – Brinjikji W, et al. J Neurointerv Surg. 2017;

LINK TO STUDY PAGE CinicalTrials.gov ID NCT01000675

Please refer to IFU for the full list of risks, contraindications, warnings, and precautions.

Explore more studies

HES Coil

GREAT: Randomized controlled multicentre study comparing HydroSoft™ / HydroFrame™ and bare platinum coils for endovascular aneurysm treatment

HES Coil

HEAT: Hydrogel Endovascular Aneurysm Treatment Trial

HES Coil

HELPS: HydroCoil Endovascular Aneurysm Occlusion and Packing Study

Request more information

By submitting, you agree to our privacy policy.